11:14 AM EDT, 08/26/2024 (MT Newswires) -- Indivior ( INDV ) said Monday that the Biomedical Advanced Research and Development Authority or BARDA has made its first order of Opvee, a nalmefene opioid overdose reversal nasal spray.

The company said $8.7 million in Project BioShield designated funding for the initial procurement will be used by BARDA, which is part of the Administration for Strategic Preparedness and Response within the US Department of Health and Human Services.

Over the next nine years, BARDA can buy additional Opvee annually under Invidior vendor-managed inventory, the company said.

Shares of Indivior ( INDV ) were up 1.9% in recent Monday trading.

Price: 12.53, Change: +0.23, Percent Change: +1.87